Table 3 Demographic data, clinical features, and laboratory indicators between patients with AKI and without AKI

Age

53.35 ± 17.91

51.55 ± 13.06

Sex

 Male

20(76.92)

189(66.08)

 Female

6(23.08)

97(33.92)

Death

 Yes

5(19.23)

6(2.09)

 No

21(80.77)

280(97.89)

ISS

24.50[22.00, 29.00]

22.00[18.00, 26.25]

Hospitalization time (d)

10.00[4.00, 21.50]

15.00[9.00, 21.00]

Myoglobin*

2.93 ± 0.38

2.41 ± 0.49

Creatine Kinase (CK)*

2.76 ± 0.39

2.61 ± 0.41

Lactate dehydrogenase (LDH)*

2.73 ± 0.17

2.58 ± 0.20

Creatine kinase-MB (CK-MB)*

1.16 ± 0.48

0.94 ± 0.47

N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP)*

2.39 ± 0.60

2.02 ± 0.43

PT (s)

12.45[11.08, 14.48]

12.00[11.30, 13.00]

APTT (s)

28.15[24.65, 31.20]

27.35[25.58, 29.60]

INR

1.11[0.98, 1.28]

1.06[1.00, 1.15]

TT (s)

15.15[14.05, 18.08]

14.40[13.40, 15.40]

D-Dimer (µg/L)

24.77[5.78, 78.80]

13.17[3.85, 22.62]

Fibrinogen (g/L)

2.38[1.47, 3.08]

2.71[2.18, 3.36]

WBC (\(\:\times\:{10}^{9}/\text{L}\))

17.43[11.52, 19.48]

12.17[9.78, 15.36]

RBC (\(\:\times\:{10}^{9}/\text{L}\))

3.77 ± 0.87

3.91 ± 0.80

PLT (\(\:\times\:{10}^{9}/\text{L}\))

184.50[129.00, 227.00]

192.00[152.75, 226.25]

NEUT%

88.05[84.08, 92.43]

88.90[83.70, 91.43]

LYM%

6.50[4.05, 10.18]

6.20[4.20, 9.75]

Total Protein (TP, g/L)

55.96[49.59, 64.39]

61.93[53.57, 67.45]

Albumin (g/L)

33.79[30.52, 40.55]

37.20[31.25, 40.46]

UREA (mmol/L)

7.61[5.77, 10.34]

5.92[4.88, 7.45]

Serum creatinine*

2.08 ± 0.31

1.77 ± 0.11